Reuters logo
BRIEF-Abbott Q3 GAAP loss per share $0.24 from continuing ops
October 19, 2016 / 12:20 PM / a year ago

BRIEF-Abbott Q3 GAAP loss per share $0.24 from continuing ops

Oct 19 (Reuters) - Abbott Laboratories -

* Abbott reports third-quarter 2016 results

* Q3 GAAP loss per share $0.24 from continuing operations

* Q3 sales $5.3 billion versus i/b/e/s view $5.29 billion

* Q3 earnings per share view $0.58 -- Thomson Reuters I/B/E/S

* Sees FY 2016 adjusted earnings per share $2.19 to $2.21 from continuing operations

* Sees FY 2016 GAAP earnings per share $0.59 to $0.61 from continuing operations

* Q3 adjusted earnings per share $0.59 from continuing operations excluding items

* Narrows full-year 2016 EPS guidance range for continuing operations

* Q3 total nutrition sales $ 1,755 million versus. $1,789 million last year

* Q3 total diagnostics sales $ 1,213 million versus $1,156 million last year

* Abbott laboratories - “Strong performance in established pharmaceuticals and medical devices led our sales growth this quarter,”

* FY2016 earnings per share view $2.20 -- Thomson Reuters I/B/E/S

* Q3 total vascular sales $708 million versus. $672 million last year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below